Lantheus Holdings (LNTH) Free Cash Flow Growth (1y) (2015 - 2026)
Lantheus Holdings (LNTH) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 44.93% |
| 10 | Lantheus Holdings | 6.97 Bn | 6.47 Bn | 230.92 Mn | 19.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.85% |
| Dec 31, 2025 | -74.57% |
| Sep 30, 2025 | -21.93% |
| Jun 30, 2025 | 61.22% |
| Mar 31, 2025 | -15.51% |
| Dec 31, 2024 | 55.05% |
| Sep 30, 2024 | 40.33% |
| Jun 30, 2024 | 231.99% |
| Mar 31, 2024 | 20.32% |
| Dec 31, 2023 | 73.16% |
| Sep 30, 2023 | -9.73% |
| Jun 30, 2023 | -164.01% |
| Mar 31, 2023 | 1,314.43% |
| Dec 31, 2022 | 4,874.56% |
| Sep 30, 2022 | 2,229.52% |
| Jun 30, 2022 | 163.84% |
| Mar 31, 2022 | -27.95% |
| Dec 31, 2021 | -81.11% |
| Sep 30, 2021 | -10.31% |
| Jun 30, 2021 | 686.47% |